AdaptHealth Corp.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $3.2B | $3.3B | $3.2B | $3.0B | $2.5B |
| Operating income | $90.9M | $263.7M | -$598.4M | $190.4M | $225.6M |
| Cost of revenue | $2.6B | $2.6B | $2.6B | $2.4B | $2.0B |
| Cash from operations | $601.8M | $541.8M | $480.7M | $373.9M | $275.7M |
| Capital expenditure | $382.4M | $306.1M | $337.5M | $391.4M | $203.3M |
| Free cash flow | $219.4M | $235.8M | $143.2M | -$17.6M | $72.4M |
| Share repurchases | $0 | $0 | $29.3M | $14.0M | $0 |
| Impairments | $1.2M | $2.7M | $830.8M | $800,000 | $0 |
| Total assets | $4.3B | $4.5B | $4.5B | $5.2B | $5.3B |
| Total liabilities | $2.8B | $2.9B | $3.0B | $3.1B | $3.2B |
| Total debt | $1.8B | $2.0B | $2.2B | $2.2B | $2.2B |
Shares outstanding 136.1M · Free float 71.9%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.